Development of a novel product for skin decontamination after exposure to chemical warfare agents

Ended Project Grant Awarded Last action

Award ID
R44NS119085
Recipient
Awarding agency
Obligated
$2,147,806

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Originally
Funding
  • $1,876,361.00 Federal
  • $271,445.00 Non-federal
Place of performance
Colorado, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$1,001,859 $0
Amendment $0 $0
Amendment $29,610 $0
Amendment $828,836 $0
Amendment $3 $0
Amendment -$3 $0
Amendment $3 $0
Amendment -$3 $0
Amendment $104,710 $0
Amendment -$104,710 $0
Amendment -$104,710 $0
Amendment $104,710 $0
Amendment -$104,710 $0
Amendment $104,710 $0
Amendment $104,710 $0
Amendment -$104,710 $0
Amendment $526,918 $0
Amendment $526,918 $0
Amendment $271,445 $0
Amendment $0 $0
Amendment $271,445 $271,445
Amendment $0 $0
Original award $423,048 $0
Show all 23

Quick answers

Who received award R44NS119085?

R44NS119085 was awarded to Armis Biopharma, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 15, 2020.

How much is award R44NS119085 worth?

$2,147,806 has been obligated on R44NS119085: $1,876,361 in federal funding and $271,445 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award